Rasha Eletreby

Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience

Aisha Elsharkawy, Maissa El Raziky, Wafaa Elakel et al. · Journal of Hepatology · 2017 · 73 citations

Hcv Patients, Direct-acting Antivirals Treatment, Egyptian Experience +10

Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic <scp>HCV</scp> genotype <scp>IV</scp> infected patients

Rasha Eletreby, Wafaa Elakel, Mohamed Said et al. · Liver International · 2016 · 60 citations

Impact of different sofosbuvir based treatment regimens on the biochemical profile of chronic hepatitis C genotype 4 patients

Aisha Elsharkawy, Rasha Eletreby, Rabab Fouad et al. · Expert Review of Gastroenterology & Hepatology · 2017 · 42 citations

Sofosbuvir‐containing regimens are safe and effective in the treatment of HCV patients with moderate to severe renal impairment

Rasha Eletreby, Magdy El‐Serafy, Mahmoud Anees et al. · Liver International · 2019 · 30 citations

Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: results of a pilot study

Ayman Yosry, Zeinab A. Soliman, Rasha Eletreby et al. · European Journal of Gastroenterology & Hepatology · 2018 · 18 citations